{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:24:58Z","timestamp":1789925098571,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.rmr.2017.08.004","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T09:27:04Z","timestamp":1530091624000},"page":"592-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suivi et prise en charge gyn\u00e9cologique chez les femmes atteintes de mucoviscidose"],"prefix":"10.1016","volume":"35","author":[{"given":"C.","family":"Rousset-Jablonski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nove-Josserand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Durupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2017.08.004_bib0425","series-title":"Registre fran\u00e7ais de la Mucoviscidose\u00a0\u2013\u00a0Bilan des donn\u00e9es 2015","author":"Cystic Fibrosis French Registry","year":"2016"},{"key":"10.1016\/j.rmr.2017.08.004_bib0430","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/humrep\/dev217","article-title":"Contraceptive practices and cervical screening in women with cystic fibrosis","volume":"30","author":"Rousset-Jablonski","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rmr.2017.08.004_bib0435","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4452","article-title":"Provider and patient attitudes regarding sexual health in young women with cystic fibrosis","volume":"137","author":"Kazmerski","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2017.08.004_bib0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ppul.23321","article-title":"Cystic fibrosis program directors\u2019 attitudes toward sexual and reproductive health in young women with CF","volume":"51","author":"Kazmerski","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0445","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/thorax.55.8.672","article-title":"Attitudes to fertility issues among adults with cystic fibrosis in Scotland. The Collaborative Group of Scottish Adult CF Centres","volume":"55","author":"Fair","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2017.08.004_bib0450","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.prrv.2010.01.002","article-title":"Contraception, communication and counselling for sexuality and reproductive health in adolescents and young adults with CF","volume":"11","author":"Tsang","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.rmr.2017.08.004_bib0455","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcf.2008.03.001","article-title":"Contraceptive practices in women with cystic fibrosis","volume":"7","author":"Plant","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2017.08.004_bib0460","first-page":"1","article-title":"La crise de la pilule en France\u00a0: vers un nouveau mod\u00e8le contraceptif\u00a0?","volume":"511","author":"Bajos","year":"2014","journal-title":"Popul Soc"},{"key":"10.1016\/j.rmr.2017.08.004_bib0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1783\/147118909788708075","article-title":"Provision of contraception services and advice for women with cystic fibrosis","volume":"35","author":"Gatiss","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.rmr.2017.08.004_bib0470","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/1054-139X(94)00096-W","article-title":"Reproductive health in young women with cystic fibrosis: knowledge, behavior and attitudes","volume":"17","author":"Sawyer","year":"1995","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.rmr.2017.08.004_bib0475","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1743-6109.2008.01049.x","article-title":"Sexual and reproductive health knowledge in cystic fibrosis female patients and their parents","volume":"6","author":"Korzeniewska","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0480","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9378(70)90254-1","article-title":"Cervical mucus in cystic fibrosis: a possible cause of infertility","volume":"108","author":"Oppenheimer","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0485","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.fertnstert.2005.10.051","article-title":"Multifollicular ovaries in female adolescents with cystic fibrosis","volume":"85","author":"Galli-Tsinopoulou","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rmr.2017.08.004_bib0490","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2011-1363","article-title":"Impaired CFTR-dependent amplification of FSH-stimulated estrogen production in cystic fibrosis and PCOS","volume":"97","author":"Chen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rmr.2017.08.004_bib0495","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcf.2014.09.008","article-title":"Cystic fibrosis and ovarian reserve: a cross-sectional study examining serum anti-mullerian hormone in young women","volume":"14","author":"Schram","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2017.08.004_bib0500","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1783\/147118901101195029","article-title":"Contraceptive practices in women with systemic lupus erythematosus and\/or antiphospholipid syndrome: what advice should we be giving?","volume":"27","author":"Lakasing","year":"2001","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.rmr.2017.08.004_bib0505","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.23712","article-title":"Risk of unintended pregnancy among women with systemic lupus erythematosus","volume":"59","author":"Schwarz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmr.2017.08.004_bib0510","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcf.2006.03.001","article-title":"Pregnancy in cystic fibrosis lung transplant recipients: case series and review","volume":"5","author":"Gyi","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2017.08.004_bib0515","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bpobgyn.2014.07.019","article-title":"Pregnancy after heart and lung transplantation","volume":"28","author":"Vos","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0520","first-page":"1","article-title":"IMAP statement on the management of HIV infection within sexual and reproductive health services","volume":"39","author":"International Medical Advisory Panel (IMAP)","year":"2005","journal-title":"IPPF Bull Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0525","series-title":"Contraceptive efficacy. Contracept. Technol. 9th edition","author":"Trussell","year":"2007"},{"key":"10.1016\/j.rmr.2017.08.004_bib0530","series-title":"Medical Eligibility Criteria for Contraceptive use. WHO Libr. Cat. Publ. Data. 4th edition, Geneva, Switzerland","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.rmr.2017.08.004_bib0535","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/sti.2003.007153","article-title":"Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions","volume":"81","author":"Minnis","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.rmr.2017.08.004_bib0540","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2017.08.004_bib0545","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0550","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297\u00a0women with breast cancer and 100,239\u00a0women without breast cancer from 54\u00a0epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2017.08.004_bib0555","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ando.2012.09.001","article-title":"Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology","volume":"73","author":"Gourdy","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/thx.53.4.285","article-title":"Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications","volume":"53","author":"Deerojanawong","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2017.08.004_bib0565","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S2213-2600(14)70231-0","article-title":"Sexual and reproductive health in cystic fibrosis: a life-course perspective","volume":"3","author":"Frayman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0570","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/TP.0b013e31827c64de","article-title":"Contraceptive options for women with a history of solid-organ transplantation","volume":"95","author":"Krajewski","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2017.08.004_bib0575","unstructured":"OrkambiTM (lumacaftor\/ivacaftor) Summary of Product Characteristics, Vertex Pharmaceuticals (Europe) Incorporated. n.d."},{"key":"10.1016\/j.rmr.2017.08.004_bib0580","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rmr.2017.08.004_bib0585","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMoa1106126","article-title":"Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis","volume":"366","author":"Chotirmall","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0590","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1465-9921-11-166","article-title":"Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice","volume":"11","author":"Wang","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2017.08.004_bib0595","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1183\/09031936.00018712","article-title":"Oral contraceptives do not appear to affect cystic fibrosis disease severity","volume":"41","author":"Kernan","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2017.08.004_bib0600","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2017.08.004_bib0605","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rmr.2017.08.004_bib0610","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.rmr.2017.08.004_bib0615","first-page":"445","article-title":"Intrauterine devices: an update","volume":"89","author":"Hardeman","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.rmr.2017.08.004_bib0620","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00016340802707473","article-title":"Infection risk and intrauterine devices","volume":"88","author":"Mart\u00ednez","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.rmr.2017.08.004_bib0625","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.rmr.2017.08.004_bib0630","series-title":"Conduite pratique de la contraception chez l\u2019homme et chez la, femme. Rapport d\u2019\u00e9laboration HAS","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2013"},{"key":"10.1016\/j.rmr.2017.08.004_bib0635","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1016\/j.rmr.2017.08.004_bib0640","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.rmr.2017.08.004_bib0645","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). JAYDESS 13,5mg\u00a0\u2013\u00a0Commission de la transparence\u00a0\u2013\u00a0Avis 2013."},{"key":"10.1016\/j.rmr.2017.08.004_bib0650","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0015-0282(16)54301-5","article-title":"Risk factors for regret after tubal sterilization: 5\u00a0years of follow-up in a prospective study","volume":"55","author":"Wilcox","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rmr.2017.08.004_bib0655","first-page":"889","article-title":"Poststerilization regret: findings from the United States Collaborative Review of Sterilization","volume":"93","author":"Hillis","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0660","unstructured":"Loi no\u00a02001-588\u00a0du 4\u00a0juillet 2001\u00a0relative \u00e0 l\u2019interruption volontaire de grossesse et \u00e0 la contraception 2001."},{"key":"10.1016\/j.rmr.2017.08.004_bib0665","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13256-015-0729-y","article-title":"Hysteroscopic sterilization in immunocompromised patients who have intrauterine devices in place: two case reports","volume":"9","author":"Ladanyi","year":"2015","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.rmr.2017.08.004_bib0670","series-title":"ESSURE\u00a0\u2013\u00a0permanent birth control\u00a0\u2013\u00a0Instructions for use","author":"Bayer Pharma","year":"2002"},{"key":"10.1016\/j.rmr.2017.08.004_bib0675","first-page":"CD001324","article-title":"Interventions for emergency contraception","author":"Cheng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2017.08.004_bib0680","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2017.08.004_bib0685","series-title":"Practical recommendations for contraception; Educ. Kit Epilepsies Vol. 4\u00a0Epilepsy Women","first-page":"96","author":"Marsh","year":"2008"},{"key":"10.1016\/j.rmr.2017.08.004_bib0690","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France over the 1980\u20132012\u00a0period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.rmr.2017.08.004_bib0695","first-page":"1923","article-title":"Cancer of the uterine cervix. Epidemiology, pathologic anatomy, diagnostic evolution, principles of treatment, staging","volume":"49","author":"Dargent","year":"1999","journal-title":"Rev Prat"},{"key":"10.1016\/j.rmr.2017.08.004_bib0700","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","article-title":"Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis","volume":"133","author":"Rositch","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rmr.2017.08.004_bib0705","series-title":"\u00c9tat des lieux et recommandations pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus en France","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","year":"2010"},{"key":"10.1016\/j.rmr.2017.08.004_bib0710","series-title":"R\u00e9f\u00e9rentiel de pratiques pour la pr\u00e9vention et le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","year":"2013"},{"key":"10.1016\/j.rmr.2017.08.004_bib0715","series-title":"Conduite \u00e0 tenir devant une patiente ayant un frottis cervico-ut\u00e9rin anormal. Actualisation. Recommandations pour la pratique clinique","author":"Agence nationale d\u2019accr\u00e9ditation et d\u2019\u00e9valuation en sant\u00e9 (ANAES)","year":"2002"},{"key":"10.1016\/j.rmr.2017.08.004_bib0720","series-title":"Pr\u00e9vention du cancer du col de l\u2019ut\u00e9rus. Recommandations pour la pratique clinique","author":"Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais (CNGOF)","year":"2007"},{"key":"10.1016\/j.rmr.2017.08.004_bib0725","series-title":"Conduite \u00e0 tenir devant une femme ayant une cytologie cervico-ut\u00e9rine anormale","author":"Institut National du Cancer (INCa)","year":"2017"},{"key":"10.1016\/j.rmr.2017.08.004_bib0730","series-title":"Calendrier des vaccinations et recommandations vaccinales","author":"Minist\u00e8re des Affaires sociales, de la Sant\u00e9 et des Droits des femmes","year":"2015"},{"key":"10.1016\/j.rmr.2017.08.004_bib0735","series-title":"Le calendrier des vaccinations et les recommandations vaccinales 2013\u00a0selon l\u2019avis du Haut Conseil de la sant\u00e9 publique","author":"Haut Conseil de la Sant\u00e9 publique","year":"2013"},{"key":"10.1016\/j.rmr.2017.08.004_bib0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejogrb.2017.12.005","article-title":"High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis","volume":"221","author":"Rousset-Jablonski","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0745","first-page":"906","article-title":"Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis","volume":"144","author":"Tizzano","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0750","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0015-0282(16)39790-4","article-title":"Water and electrolytes in cervical mucus from patients with cystic fibrosis","volume":"24","author":"Kopito","year":"1973","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rmr.2017.08.004_bib0755","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0015-0282(97)81358-1","article-title":"The cystic fibrosis transmembrane regulator gene is expressed in the human endocervix throughout the menstrual cycle","volume":"67","author":"Hayslip","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rmr.2017.08.004_bib0760","doi-asserted-by":"crossref","first-page":"1201e19","DOI":"10.1016\/j.fertnstert.2007.08.063","article-title":"Infertility and abnormal cervical mucus in two sisters who are compound heterozygotes for the cystic fibrosis (CF) DeltaF508\u00a0and R117H\/7T mutations","volume":"90","author":"Schoyer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rmr.2017.08.004_bib0765","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/modpathol.2015.54","article-title":"Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk","volume":"28","author":"Yang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0770","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10147-014-0680-8","article-title":"Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia","volume":"20","author":"Iwata","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0775","first-page":"118","article-title":"Cytokine status of cervical mucus in women with transitory and persistent course of papillomavirus infection","author":"Telesheva","year":"2012","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0780","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/ajt.13053","article-title":"HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study","volume":"15","author":"Meeuwis","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2017.08.004_bib0785","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/PGP.0b013e3182a54ada","article-title":"Prevalence and genotypes of HPV in female renal transplant recipients in North India","volume":"33","author":"Aggarwal","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0790","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.healun.2003.07.018","article-title":"Sexual health issues after lung transplantation: importance of cervical screening","volume":"23","author":"Malouf","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2017.08.004_bib0795","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.critrevonc.2012.02.008","article-title":"HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients","volume":"84","author":"Hinten","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.rmr.2017.08.004_bib0800","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2017.08.004_bib0805","series-title":"D\u00e9pistage du cancer du sein en France\u00a0: identification des femmes \u00e0 haut risque et modalit\u00e9s de, d\u00e9pistage. Recommandations de Sant\u00e9 Publique\u00a0; HAS","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2014"},{"key":"10.1016\/j.rmr.2017.08.004_bib0810","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rmr.2017.08.004_bib0815","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2016.07.011","article-title":"Cancer risk among lung transplant recipients with cystic fibrosis","volume":"16","author":"Fink","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2017.08.004_bib0820","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ajt.13925","article-title":"Risk factors for de novo malignancy following lung transplantation","volume":"17","author":"Magruder","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2017.08.004_bib0825","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/bmj.322.7301.1521","article-title":"Questionnaire survey of urinary incontinence in women with cystic fibrosis","volume":"322","author":"Orr","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2017.08.004_bib0830","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.110.2.e22","article-title":"Urinary incontinence in female adolescents with cystic fibrosis","volume":"110","author":"Nixon","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2017.08.004_bib0835","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1569-1993(03)00088-2","article-title":"Treatment of urinary incontinence in cystic fibrosis","volume":"2","author":"McVean","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2017.08.004_bib0840","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/bmj.308.6944.1609","article-title":"Vulvovaginal candidiasis in young women with cystic fibrosis","volume":"308","author":"Sawyer","year":"1994","journal-title":"BMJ"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T16:36:55Z","timestamp":1531586215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518300950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0761842518300950"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2017.08.004","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi et prise en charge gyn\u00e9cologique chez les femmes atteintes de mucoviscidose","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of SPLF.","name":"copyright","label":"Copyright"}]}}